Results 121 to 130 of about 179,564 (341)
Oral pyogenic granuloma: An
, 2021 Jaqueline Lemes Ribeiro +5 more
openalex +2 more sources
Extramedullary Plasmacytoma of Soft Tissues and Gingiva [PDF]
, 2012 Extramedullary plasmacytoma (EMP) is a rare plasma cell neoplasm of soft tissue without bone marrow involvement or other systemic characteristics of multiple myeloma. It accounts for 3% of all plasma cell tumors.
Jena, M, Kaler, AK, Shankar, A
core
Clinical Anatomy, EarlyView.ABSTRACT The buccomandibular space is a potential space located within the oral and maxillofacial regions. This morphological study aimed to provide a detailed anatomical description and ultrasonographic examination of the buccomandibular space and its adjacent structures, to discuss its clinical significance—particularly in relation to pathological ...
Hyun‐Ju Ji +5 more
wiley +1 more source
Research progress on immunometabolism regulatory mechanisms of tuberculous granuloma
生物医学转化Tuberculosis (TB) remains a significant threat to human health. Tuberculous granuloma is a typical pathological feature of TB and also a "refuge" for Mycobacterium tuberculosis (Mtb) to escape host immune defense and achieve long-term survival and latent
Yang Hua, Ge Baoxue
doaj +1 more source
Perigraftitis treatment and histology: A case report
Clinical Advances in Periodontics, EarlyView.Abstract Background Currently, the two diagnoses of inflammatory peri‐implant diseases are peri‐implant mucositis and peri‐implantitis. The etiology of peri‐implant mucositis and peri‐implantitis is bacterial colonization of the implant. Thus, removal of the implant should eliminate the infection and allow the inflammation to resolve. However, at least
Jonathan H. Do +2 more
wiley +1 more source
Clinical Safety of Extended Interval Dosing of Nivolumab in Patients with Melanoma
Clinical Pharmacology &Therapeutics, EarlyView.Extended interval dosing regimens of immune checkpoint inhibitors have been implemented widely. However, their approval was mainly based on pharmacokinetic modeling and simulations. Consequently, comparative safety data of extended interval dosing regimens in a real‐world setting are limited.
Ruben Malmberg +10 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 869-878, April 2025.Abstract Aims The prognostic role of high‐sensitivity cardiac troponin T (hs‐cTnT) as a biomarker in patients with cardiac sarcoidosis (CS) has yet to be fully determined, especially when compared with B‐type natriuretic peptide (BNP). Methods and Results In this post‐hoc analysis of the ILLUMINATE‐CS (ILLUstration of the Management and prognosIs of ...
Yuichi Baba +10 more
wiley +1 more source
Environmental and Molecular Mutagenesis, EarlyView.Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons +17 more
wiley +1 more source